---
{"dg-publish":true,"permalink":"/USMLE/Immunology/Complement system/","tags":["t1"]}
---

![Pasted image 20240318194037.png](/img/user/appendix/Pasted%20image%2020240318194037.png)
- Activation pathways
	- Classical pathway
		- <span style="background:rgba(240, 200, 0, 0.2)">Activated by IgM or IgG complexes binding to the pathogen</span>![Pasted image 20241228221355.png](/img/user/appendix/Pasted%20image%2020241228221355.png)
- Effect
	- Membrane attack complex (MAC)
		- Formed by C5b–C9
		- Lysis of bacteria (especially gram‑negative bacteria) by perforation of the cell wall
	- <span style="background:rgba(240, 200, 0, 0.2)">Opsonization</span>
		- <span style="background:rgba(240, 200, 0, 0.2)">Increases the susceptibility of target particles (e.g., bacteria) to phagocytosis</span>![Pasted image 20240224220021.png](/img/user/appendix/Pasted%20image%2020240224220021.png)
		- Attachment of opsonins (e.g., [[USMLE/Immunology/Immunoglobulins\|immunoglobulins]]) causes structural changes that facilitate interaction with immune cells.
		- <span style="background:rgba(240, 200, 0, 0.2)">C3b and IgG are the two main opsonins for bacteria</span>![L16733.jpg](/img/user/appendix/L16733.jpg)
		- <span style="background:rgba(240, 200, 0, 0.2)">C3b is also involved in eliminating immune complexes.</span>
			- Deficiency of C3b will increase risk of [[USMLE/Immunology/Systemic lupus erythematosus\|SLE]]
			- C3 is decreased in [[USMLE/Renal/Poststreptococcal glomerulonephritis\|PSGN]], [[USMLE/Renal/Diffuse proliferative glomerulonephritis\|DPGN]]
	- <span style="background:rgba(240, 200, 0, 0.2)">Anaphylaxis: activation of mast cells and granulocytes via C3a/C4a/C5a</span>
	- <span style="background:rgba(240, 200, 0, 0.2)">Chemotaxis: attraction of neutrophils via C5a</span>

>[!Mnemonic] 
>- C3<font color="#ffc000">b</font> binds to <font color="#ffc000">b</font>acteria.
>- C3<font color="#ffc000">a</font>, C4<font color="#ffc000">a</font>, C5<font color="#ffc000">a</font> lead to mast-cell <font color="#ffc000">a</font>ctivation and <font color="#ffc000">a</font>naphylaxis.
# Complement disorders
## C1 esterase inhibitor deficiency
<span style="background:rgba(240, 200, 0, 0.2)">Just think it as C1 inhibitor, as it actually has nothing to do with esterase.</span>
- Etiology
	- Autosomal dominant inheritance
	- <span style="background:rgba(240, 200, 0, 0.2)">Unregulated activation of kallikrein → ↑ bradykinin → [[USMLE/Immunology/Angioedema\|angioedema]]</span>![highresdefault_L68045.jpg](/img/user/appendix/highresdefault_L68045.jpg)
- Clinical features
	- <span style="background:rgba(240, 200, 0, 0.2)">Causes hereditary [[USMLE/Immunology/Angioedema\|angioedema]]</span>
		- Recurrent angioedemas provoked by triggers (e.g., trauma, surgery, infections, and drugs)
	- <span style="background:rgba(240, 200, 0, 0.2)">Not associated with itching or urticaria</span>
		- <span style="background:rgba(240, 200, 0, 0.2)">Not involve histamine</span>, which is released in [[USMLE/Immunology/Type I hypersensitivity reaction\|Type I hypersensitivity reaction]] by mast cells
- Diagnostic findings
	- <span style="background:rgba(240, 200, 0, 0.2)">↑ Bradykinin levels</span>
	- <span style="background:rgba(240, 200, 0, 0.2)">Low C4 levels</span>
	- Strong contraindication for ACE inhibitors
## Complement deficiencies
![Pasted image 20240405112726.png](/img/user/appendix/Pasted%20image%2020240405112726.png)
- Recurrent, severe childhood infections (e.g., upper respiratory tract infections, pneumonia, meningitis) with encapsulated bacteria (e.g., <span style="background:rgba(240, 200, 0, 0.2)">N. meningitidis</span>, H. influenzae, S. pneumoniae)
